Ca2+, Astrocyte Activation and Calcineurin/NFAT Signaling in Age-Related Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Mounting evidence supports a fundamental role for Ca2+ dysregulation in astrocyte activation. Though the activated astrocyte phenotype is complex, cell-type targeting approaches have revealed a number of detrimental roles of activated astrocytes involving neuroinflammation, release of synaptotoxic factors, and loss of glutamate regulation. Work from our lab and others has suggested that the Ca2+/calmodulin dependent protein phosphatase, calcineurin, provides a critical link between Ca2+ dysregulation and the activated astrocyte phenotype. A proteolyzed, hyperactivated form of CN appears at high levels in activated astrocytes in both human tissue and rodent tissue around regions of amyloid and vascular pathology. Similar upregulation of the calcineurin-dependent transcription factor NFAT4 also appears in activated astrocytes in mouse models of Alzheimer’s disease and traumatic brain injury. Major consequences of hyperactivated calcineurin/NFAT4 signaling in astrocytes are neuroinflammation, synapse dysfunction, and glutamate dysregulation/excitotoxicity, which will be covered in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
The Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
Molecular dissection of reactive astrogliosis and glial scar formation
Sofroniew, M. V. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.08.002 · Cited by 2,594 · cited 9×
“In an aggressive mouse model of AD (i.e., 5xFAD mice), ∆CN was similarly observed in activated astrocytes in the hippocampus, increasing in direct proportion to elevated GFAP levels (Sompol et al., 2017).”
InfluentialGenomic analysis of reactive astrogliosis
Zamanian, J. L., Xu, L., Foo, L. C., Nouri, N., Zhou, L., Giffard, R. G., & Barres, B. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6221-11.2012 · Cited by 2,404
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Astrocyte reactivity and reactive astrogliosis: costs and benefits
Pekny, M., & Pekna, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00041.2013 · Cited by 934
Lian, H., Yang, L., Cole, A., Sun, L., Chiang, A. C.-A., Fowler, S. W., Shim, D. J., Rodriguez-Rivera, J., Taglialatela, G., Jankowsky, J. L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.11.018 · Cited by 697
Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC
Kucukdereli, H., Allen, N. J., Lee, A. T., Feng, A., Ozlu, M. I., Conatser, L. M., Chakraborty, C., Workman, G., Weaver, M., Sage, E. H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104977108 · Cited by 642
Kuchibhotla, K. V., Goldman, S. T., Lattarulo, C. R., Wu, H.-Y., Hyman, B. T., & Bacskai, B. J. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.008 · Cited by 614
Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Shi, Q., Chowdhury, S., Ma, R., Le, K. X., Hong, S., Caldarone, B. J., Stevens, B., & Lemere, C. A. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6295 · Cited by 593
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease
D'Amelio, M., Cavallucci, V., Middei, S., Marchetti, C., Pacioni, S., Ferri, A., Diamantini, A., De Zio, D., Carrara, P., Battistini, L., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2709 · Cited by 572 · cited 1×
“Similar changes are often recapitulated to a significant degree in corresponding animal models of aging and neurodegeneration (Foster et al., 2001; Huang et al., 2005; Norris et al., 2005; Shioda et al., 2006; Reese et al., 2008; Mukherjee et al., 2010; Wu et al., 2010; D’Amelio et al., 2011; Martin et al., 2012; Rose…”
BackgroundPhosphoprotein Phosphatase Activities in Alzheimer Disease Brain
Gong, C., Singh, T. J., Grundke‐Iqbal, I., & Iqbal, K. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03603.x · Cited by 527 · cited 1×
“Many commercial CN antibodies (directed to the CN carboxyl terminus) do not detect ∆CN in Western blot applications, which may explain why earlier studies failed to observe elevated CN in neurodegenerative conditions like AD (Gong et al., 1993; Ladner et al., 1996; Lian et al., 2001).”
Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease
Masliah, E., Hansen, L., Alford, M., Deteresa, R., & Mallory, M. (1996) · Annals of Neurology · doi:10.1002/ana.410400512 · Cited by 476 · cited 1×
“Loss of EAAT2 has been observed in several human neurodegenerative conditions including AD (Masliah et al., 1996; Abdul et al., 2009; Simpson et al., 2010), Alexander disease (Tian et al.”
BackgroundAstrocytes in physiological aging and Alzheimer’s disease
Rodríguez-Arellano, J. J., Parpura, V., Zorec, R., & Verkhratsky, A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.007 · Cited by 439
Regulation of F-Actin Stability in Dendritic Spines by Glutamate Receptors and Calcineurin
Halpain, S., Hipolito, A., & Saffer, L. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09835.1998 · Cited by 408 · cited 1×
“These results are reminiscent of studies in neurons, where CN has been long-known to regulate rapid cytoskeletal reorganization in dendritic spines and growth cones (Halpain et al., 1998; Wen et al., 2004).”
ResultAstrocyte phenotype in relation to Alzheimer‐type pathology in the ageing brain
Simpson, J. E., Ince, P. G., Lace, G., Forster, G., Shaw, P. J., Matthews, F., Savva, G., Brayne, C., & Wharton, S. B. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.015 · Cited by 381
Wu, H.-Y., Hudry, E., Hashimoto, T., Kuchibhotla, K., Rozkalne, A., Fan, Z., Spires-Jones, T., Xie, H., Arbel-Ornath, M., Grosskreutz, C. L., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4456-09.2010 · Cited by 367
Three-dimensional Ca 2+ imaging advances understanding of astrocyte biology
Bindocci, E., Savtchouk, I., Liaudet, N., Becker, D., Carriero, G., & Volterra, A. (2017) · Science · doi:10.1126/science.aai8185 · Cited by 342
Delekate, A., Füchtemeier, M., Schumacher, T., Ulbrich, C., Foddis, M., & Petzold, G. C. (2014) · Nature Communications · doi:10.1038/ncomms6422 · Cited by 332 · cited 1×
“Similar functional indices of Ca2+ dysregulation have been noted in animal models of AD (Takano et al., 2007; Kuchibhotla et al., 2009; Delekate et al., 2014), brain edema (Thrane et al.”
BackgroundPetr, G. T., Sun, Y., Frederick, N. M., Zhou, Y., Dhamne, S. C., Hameed, M. Q., Miranda, C., Bedoya, E. A., Fischer, K. D., Armsen, W., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4255-14.2015 · Cited by 297 · cited 1×
“Functional knockdown of EAAT2/GLT-1 very typically causes synaptic hyperexcitability, altered synaptic plasticity, excitotoxicity and a variety of functional deficits depending on the brain region affected (Rothstein et al., 1996; Rao et al., 2001; Selkirk et al., 2005; Petr et al., 2015; Moidunny et al., 2016).”
BackgroundDeciphering the astrocyte reaction in Alzheimer's disease
Perez-Nievas, B. G., & Serrano-Pozo, A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00114 · Cited by 282 · cited 1×
“, NFκB, JAK/STAT, FOX proteins, peroxisome proliferator-activated receptors (PPARs) and activator protein-1 (AP-1), among others) have been implicated in shaping gene expression programs involved in astrocyte activation (Perez-Nievas and Serrano-Pozo, 2018).”
BackgroundCritical role of aquaporin-4 (AQP4) in astrocytic Ca 2+ signaling events elicited by cerebral edema
Thrane, A. S., Rappold, P. M., Fujita, T., Torres, A., Bekar, L. K., Takano, T., Peng, W., Wang, F., Rangroo Thrane, V., Enger, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015217108 · Cited by 254
Norris, C. M., Kadish, I., Blalock, E. M., Chen, K.-C., Thibault, V., Porter, N. M., Landfield, P. W., & Kraner, S. D. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0365-05.2005 · Cited by 229
Self-citationThe role of complement and activated microglia in the pathogenesis of Alzheimer's disease
Eikelenboom, P., & Veerhuis, R. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00108-x · Cited by 206 · cited 1×
“C3 levels drop during maturation, but then reappear under pathological conditions, like AD (Eikelenboom and Veerhuis, 1996; Zabel and Kirsch, 2013).”
BackgroundAmyloid beta deregulates astroglial mGluR5‐mediated calcium signaling via calcineurin and Nf‐kB
Lim, D., Iyer, A., Ronco, V., Grolla, A. A., Canonico, P. L., Aronica, E., & Genazzani, A. A. (2013) · Glia · doi:10.1002/glia.22502 · Cited by 169
Schallier, A., Smolders, I., Van Dam, D., Loyens, E., De Deyn, P. P., Michotte, A., Michotte, Y., & Massie, A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101005 · Cited by 109 · cited 1×
“Similar changes have been reported in corresponding animal models (Masliah et al., 2000; Mookherjee et al., 2011; Schallier et al., 2011; Hefendehl et al., 2016; Sompol et al., 2017).”
Kinetics of calmodulin binding to calcineurin
Quintana, A. R., Wang, D., Forbes, J. E., & Waxham, M. N. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.152 · Cited by 82
Polli, J. W., Billingsley, M. L., & Kincaid, R. L. (1991) · Developmental Brain Research · doi:10.1016/0165-3806(91)90071-p · Cited by 78
Astroglial Calcium Signalling in Alzheimer's Disease
Verkhratsky, A., Rodríguez-Arellano, J. J., Parpura, V., & Zorec, R. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.088 · Cited by 55
Cited by
Questions and (some) answers on reactive astrocytes
Escartin, C., Guillemaud, O., & Carrillo‐de Sauvage, M. (2019) · Glia · doi:10.1002/glia.23687 · Cited by 275
Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer’s disease
Kumar, A., Fontana, I. C., & Nordberg, A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15565 · Cited by 150
Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer’s Disease
Kang, Y. J., Diep, Y. N., Tran, M., & Cho, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249591 · Cited by 36
Metadata
- Authors
- Sompol, P., & Norris, C. M.
- Venue
- Frontiers in Aging Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2018-07-09
- Volume
- 10
- Pages
- 199-199
- ISSN
- 1663-4365 (ISSN-L)
- OpenAlex
- W2808363189
- Cited by
- 82
- References
- 30
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.